Chamberlain et al. using adeno-associated virus (AAV) targeting vector have successfully inactivated mutant COL1A1 (13) and COL1A2 (14) genes in OI mesenchymal stem cells (MSCs), thus restoring the production of normal type 1 procollagen. This evidence concerns the gene COL1A1 and osteogenesis imperfecta.